Adcock Ingram Holdings Ltd (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH82096D
- Pages: 37
- November 2018
- Total Views:1155
- Region : Africa
- GlobalData
- Equity Research Report
Details
Summary
Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company's product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.
Adcock Ingram Holdings Ltd (AIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12
Private Equity 13
Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13
Partnerships 14
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Asset Transactions 16
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16
Acquisition 17
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd-Key Competitors 28
Adcock Ingram Holdings Ltd-Key Employees 29
Adcock Ingram Holdings Ltd-Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32
Corporate Communications 34
Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34
Other Significant Developments 35
Aug 29, 2018: Adcock Ingram Holdings-Group annual results and cash dividend declaration 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12
Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd, Key Competitors 28
Adcock Ingram Holdings Ltd, Key Employees 29
Adcock Ingram Holdings Ltd, Subsidiaries 30
Adcock Ingram Holdings Ltd, Joint Venture 31
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Adcock Ingram Holdings Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company's product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.
Adcock Ingram Holdings Ltd (AIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12
Private Equity 13
Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13
Partnerships 14
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Asset Transactions 16
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16
Acquisition 17
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd-Key Competitors 28
Adcock Ingram Holdings Ltd-Key Employees 29
Adcock Ingram Holdings Ltd-Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32
Corporate Communications 34
Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34
Other Significant Developments 35
Aug 29, 2018: Adcock Ingram Holdings-Group annual results and cash dividend declaration 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12
Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd, Key Competitors 28
Adcock Ingram Holdings Ltd, Key Employees 29
Adcock Ingram Holdings Ltd, Subsidiaries 30
Adcock Ingram Holdings Ltd, Joint Venture 31
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Adcock Ingram Holdings Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020